Health Canada drug identification number

DIN 02435071 — OXALIPLATIN INJECTION 5 MG

OXALIPLATIN INJECTION is a solution of Oxaliplatin marketed by TEVA CANADA LIMITED. The full Oxaliplatin monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02435071
Brand name
OXALIPLATIN INJECTION
Active ingredient
Oxaliplatin
Strength
5 MG
Dosage form
SOLUTION
Route
INTRAVENOUS
Manufacturer
TEVA CANADA LIMITED
Health Canada status
MARKETED
Drug class
Platinum-based antineoplastic agent

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Oxaliplatin products

DINBrandStrengthFormManufacturerStatus
02444763 OXALIPLATIN 5 MG SOLUTION PFIZER CANADA ULC MARKETED
02436957 OXALIPLATIN INJECTION 5 MG SOLUTION SANDOZ CANADA INCORPORATED MARKETED
02457423 OXALIPLATIN INJECTION, USP 5 MG SOLUTION FRESENIUS KABI CANADA LTD MARKETED
02458403 OXALIPLATIN INJECTION, USP 5 MG SOLUTION DR REDDY'S LABORATORIES LTD MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.